CUV - CLINUVEL PHARMACEUTICALS LIMITED

[paul jackson]

With regards to Fisher's latest topical research (below), here is the study from the journal Cell for all you budding scientists out there:

 

https://www.cell.com/cell/fulltext/S0092-8674(21)00757-1

[nipper]

just for the sake of sentimentality ...

 

CUV is the top performer today, up 10%, and over $37 a share.

 

 

[macgyver]

Well. Paul Jackson has been exposed as a fop. It appears the guy who posts regular financial analyses has called it right on the sp so far. Looking for $80 by the end of the year, farfetched? No, not if the last four weeks are anything to go by.

 

 

Those newcomers new to Clinuvel would do well to head over to Sharetease. You will not get any valuable information, opinions here, or anything of worth for that matter. Just grizzled knobs bitter they lost a whole bunch of posters

[Diggy]

SUP MAC.

 

Where's Kiwi? LOL

[nipper]

from the AFR:

Clinuvel Pharmaceuticals, [seen by some to be] a market darling that has developed a drug for a rare skin disease for which it now faces competition from a Japanese rival, faces a second strike and a possible spill at its annual meeting.

Quote

Chairman Willem Blijdorp urged shareholders to back the board at the Wednesday AGM, arguing the board has taken steps to address concerns about the CEO pay raised at last year’s meeting by shareholders.

Quote

Proxy firm Ownership Matters told clients to vote against the remuneration report at the AGM on November 10. If 25 per cent or more shareholders vote against the pay report again after the first strike last year, a spill motion is triggered.

Ownership Matters told institutional investors to vote against the spill motion, preferring to give the biotech an opportunity to mend its ways. Long serving CEO Dr Philippe Wolgen has a service agreement that comes to an end this year, leaving room for an overhaul.

............ down 8%

[nipper]

Oh, fickle markets. 

All the opinionating in the world cannot keep the SP from retracing. From mid twenties , the run that saw $43 by Sept 2021 seems to have come undone. Now back to $27.

When is that patent running out?

[nipper]

so much nonsense was written by the true believers/ polished deceivers/ total deluders / ....

..... and where are we now?

 

Hahahahahaha.